{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T06:28:44Z","timestamp":1769927324150,"version":"3.49.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:sec>\n            <jats:title>Rationale<\/jats:title>\n            <jats:p>We evaluated K-means clustering to classify amyloid brain PETs as positive or negative.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients and Methods<\/jats:title>\n            <jats:p>Sixty-six participants (31 men, 35 women; age range, 52\u201381 years) were recruited through a multicenter observational study: 19 cognitively normal, 25 mild cognitive impairment, and 22 dementia (11 Alzheimer disease, 3 subcortical vascular cognitive impairment, and 8 Parkinson\u2013Lewy Body spectrum disorder). As part of the neurocognitive and imaging evaluation, each participant had an <jats:sup>18<\/jats:sup>F-flutemetamol (Vizamyl, GE Healthcare) brain PET. All studies were processed using Cortex ID software (General Electric Company, Boston, MA) to calculate SUV ratios in 19 regions of interest and clinically interpreted by 2 dual-certified radiologists\/nuclear medicine physicians, using MIM software (MIM Software Inc, Cleveland, OH), blinded to the quantitative analysis, with final interpretation based on consensus. K-means clustering was retrospectively used to classify the studies from the quantitative data.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Based on clinical interpretation, 46 brain PETs were negative and 20 were positive for amyloid deposition. Of 19 cognitively normal participants, 1 (5%) had a positive <jats:sup>18<\/jats:sup>F-flutemetamol brain PET. Of 25 participants with mild cognitive impairment, 9 (36%) had a positive <jats:sup>18<\/jats:sup>F-flutemetamol brain PET. Of 22 participants with dementia, 10 (45%) had a positive <jats:sup>18<\/jats:sup>F-flutemetamol brain PET; 7 of 11 participants with Alzheimer disease (64%), 1 of 3 participants with vascular cognitive impairment (33%), and 2 of 8 participants with Parkinson\u2013Lewy Body spectrum disorder (25%) had a positive <jats:sup>18<\/jats:sup>F-flutemetamol brain PET. Using clinical interpretation as the criterion standard, K-means clustering (K = 2) gave sensitivity of 95%, specificity of 98%, and accuracy of 97%.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>K-means clustering may be a powerful algorithm for classifying amyloid brain PET.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rlu.0000000000003668","type":"journal-article","created":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T16:18:48Z","timestamp":1619108328000},"page":"616-620","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Exploratory Assessment of K-means Clustering to Classify 18F-Flutemetamol Brain PET as Positive or Negative"],"prefix":"10.1097","volume":"46","author":[{"given":"Katherine","family":"Zukotynski","sequence":"first","affiliation":[{"name":"Department of Medicine and Radiology, McMaster University, Hamilton"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra E.","family":"Black","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip H.","family":"Kuo","sequence":"additional","affiliation":[{"name":"Departments of Medical Imaging, Medicine, and Biomedical Engineering, University of Arizona Cancer Center, University of Arizona, Tucson, AZ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aparna","family":"Bhan","sequence":"additional","affiliation":[{"name":"LC Campbell Cognitive Neurology Research Unit, Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, University of Toronto"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Adamo","sequence":"additional","affiliation":[{"name":"LC Campbell Cognitive Neurology Research Unit, Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, University of Toronto"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J.M.","family":"Scott","sequence":"additional","affiliation":[{"name":"LC Campbell Cognitive Neurology Research Unit, Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, University of Toronto"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Masellis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjeev","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinne E.","family":"Fischer","sequence":"additional","affiliation":[{"name":"Keenan Research Centre for Biomedical Science, St Michael\u2019s Hospital, University of Toronto"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Carmela","family":"Tartaglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony E.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David F.","family":"Tang-Wai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morris","family":"Freedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Vasdev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Gaudet","sequence":"additional","affiliation":[{"name":"Department of Electrical and Computer Engineering, University of Waterloo, Waterloo, Ontario, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,4,21]]},"reference":[{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/alz.12105","article-title":"Recommendations of the 5th Canadian Concensus Conference on the diagnosis and treatment of dementia","volume":"16","year":"2020","journal-title":"Alzheimers Dement"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2214\/AJR.18.19822","article-title":"PET\/CT of dementia","volume":"211","year":"2018","journal-title":"AJR Am J Roentgenol"},{"key":"bib4-20250621","first-page":"148","article-title":"The possibility of designing machines which learn diagnostic. The zero-systems of types and pathotypes in endocrinology","volume":"3","year":"1961","journal-title":"Act Nerv Super (Praha)"},{"key":"bib5-20250621","first-page":"801","article-title":"Sur la division des corps mat\u00e9riels en parties","volume":"4","year":"1957","journal-title":"Bull Acad Polon Sci"},{"key":"bib6-20250621","first-page":"281","article-title":"Some methods for classification and analysis of multivariate observations","year":"1967","journal-title":"Proc Berkeley Symp Mathematical Statistics and Probability"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2967\/jnumed.118.223495","article-title":"Machine learning in nuclear medicine: part 1\u2014introduction","volume":"60","year":"2019","journal-title":"J Nucl Med"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","year":"2004","journal-title":"J Intern Med"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations form the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","year":"2011","journal-title":"Alzheimers Dement"},{"key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","year":"2011","journal-title":"Alzheimers Dement"},{"key":"bib12-20250621","first-page":"1","article-title":"Automated quantification of 18F-flutemetamol PET activity for categorizing scans as negative or positive for brain amyloid: concordance with visual image reads","volume":"55","year":"2014","journal-title":"J Nucl Med"},{"key":"bib13-20250621","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/brain\/awm336","article-title":"11C PiB and structural MRI provide complementary information in imaging of Alzheimer\u2019s disease and amnestic mild cognitive impairment","volume":"131","year":"2008","journal-title":"Brain"},{"key":"bib14-20250621","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2967\/jnumed.119.231837","article-title":"Machine learning in nuclear medicine: part 2-neural networks and clinical aspects","volume":"62","year":"2021","journal-title":"J Nucl Med"},{"key":"bib16-20250621","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","article-title":"Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years","volume":"70","year":"2011","journal-title":"J Neuropathol Exp Neurol"},{"key":"bib17-20250621","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S1474-4422(05)70221-0","article-title":"Poststroke dementia","volume":"4","year":"2005","journal-title":"Lancet Neurol"},{"key":"bib18-20250621","first-page":"619","article-title":"Dementia with Lewy bodies: definition, diagnosis, and pathogenic relationship to Alzheimer\u2019s disease","volume":"3","year":"2007","journal-title":"Neuropsychiatr Dis Treat"},{"key":"bib19-20250621","first-page":"330","article-title":"Parkinson disease, dementia, and Alzheimer disease: clinicopathological correlations","volume":"7","year":"1980","journal-title":"Ann Neurology"},{"key":"bib20-20250621","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s11064-006-9140-9","article-title":"Interaction between A\u03b2 peptide and \u03b1 synuclein: molecular mechanisms in overlapping pathology of Alzheimer\u2019s and Parkinson\u2019s in dementia with Lewy body disease","volume":"31","year":"2006","journal-title":"Neurochem Res"},{"key":"bib21-20250621","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3233\/JAD-161074","article-title":"Amyloid-\u03b2 deposition and long-term progression in mild cognitive impairment due to Alzheimer\u2019s disease defined with amyloid PET imaging","volume":"57","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"bib22-20250621","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00259-012-2237-2","article-title":"A European multicentre PET study of fibrillar amyloid in Alzheimer\u2019s disease","volume":"40","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib23-20250621","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1212\/01.wnl.0000261919.22630.ea","article-title":"Imaging beta-amyloid burden in aging and dementia","volume":"68","year":"2007","journal-title":"Neurology"},{"key":"bib24-20250621","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.2967\/jnumed.111.089730","article-title":"Amyloid imaging with (18)F-florbetaben in Alzheimer disease and other dementias","volume":"52","year":"2011","journal-title":"J Nucl Med"},{"key":"bib25-20250621","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.nbd.2008.12.008","article-title":"Cortical PIB binding in Lewy body disease is associated with Alzheimer-like characteristics","volume":"34","year":"2009","journal-title":"Neurobiol Dis"},{"key":"bib26-20250621","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/WAD.0000000000000144","article-title":"Amyloid PET screening for enrichment of early-stage Alzheimer disease clinical trials\u2014experience in a phase 1b clinical trial","volume":"30","year":"2016","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"bib27-20250621","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","year":"1991","journal-title":"Acta Neuropathol"},{"key":"bib28-20250621","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.2010.2008","article-title":"Use of florbetapir-PET for imaging beta-amyloid pathology","volume":"305","year":"2011","journal-title":"JAMA"},{"key":"bib29-20250621","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/mp.12025","article-title":"Comparison of five cluster validity indices performance in brain [18F]FET-PET image segmentation using k-means","volume":"44","year":"2017","journal-title":"Med Phys"},{"key":"bib30-20250621","doi-asserted-by":"crossref","first-page":"e0199379","DOI":"10.1371\/journal.pone.0199379","article-title":"Voxel-based 18F-FET PET segmentation and automatic clustering of tumor voxels: a significant association with IDH1 mutation status and survival in patients with gliomas","volume":"13","year":"2018","journal-title":"PLoS One"},{"key":"bib31-20250621","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3389\/fnagi.2018.00230","article-title":"Clustering analysis of FDG-PET imaging in primary progressive aphasia","volume":"10","year":"2018","journal-title":"Front Aging Neurosci"},{"key":"bib32-20250621","first-page":"6470","article-title":"Early detection and characterization of Alzheimer\u2019s disease in clinical scenarios using Bioprofile concepts and K-means","volume":"2011","year":"2011","journal-title":"Conf Proc IEEE Eng Med Biol Soc"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003668","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T21:03:30Z","timestamp":1750539810000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,21]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003668","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4,21]]}}}